LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Imaging Methods of Joint Damage in Early Rheumatoid Arthritis.

    Sizova, Lyudmila

    Current rheumatology reviews

    2015  Volume 11, Issue 1, Page(s) 64–67

    Abstract: Rheumatoid arthritis (RA) is an autoimmune connective tissue disease of unknown etiology with development of persistent and erosive arthritis ultimately resulting in disability. The prevalence of RA is about 0.5-1% in adults worldwide. Radiographic ... ...

    Abstract Rheumatoid arthritis (RA) is an autoimmune connective tissue disease of unknown etiology with development of persistent and erosive arthritis ultimately resulting in disability. The prevalence of RA is about 0.5-1% in adults worldwide. Radiographic changes in the joints at early stages of the disease are often absent. Accordingly, there is a need for instrumental methods of diagnosis with greater sensitivity. These include magnetic resonance imaging and ultrasound of joints. The paper reviews the instrumental methods of diagnosis of joint damage in early RA according to the existing literature of PubMed database. Selection criteria were original articles in the English language reporting «X-ray», «MRI» and «ultrasound» in patients with early RA.
    Language English
    Publishing date 2015
    Publishing country United Arab Emirates
    Document type Journal Article
    ISSN 1875-6360
    ISSN (online) 1875-6360
    DOI 10.2174/1573397111666150522094405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis.

    Sizova, Lyudmila

    Human immunology

    2012  Volume 73, Issue 4, Page(s) 389–392

    Abstract: The aim of this study was to evaluate the usefulness of antibodies to modified citrullinated vimentin (anti-MCV) for diagnosing early rheumatoid arthritis (RA) and to examine the correlations between anti-MCV and clinical parameters as well as ... ...

    Abstract The aim of this study was to evaluate the usefulness of antibodies to modified citrullinated vimentin (anti-MCV) for diagnosing early rheumatoid arthritis (RA) and to examine the correlations between anti-MCV and clinical parameters as well as radiographic and ultrasound data. Our results suggest that anti-MCV has a sensitivity and specificity of 53.3 and 83.3%, respectively, and a positive prognostic value of 96% in patients with early RA. Anti-MCV antibodies were observed in 48.5% of rheumatoid factor (RF)-negative RA patients in data from a latex test and in 35.7% of patients with negative results for immunoglobulin (Ig)-M-RF. The positive result for both anti-MCV and IgM-RF has a sensitivity of 42.2% and a specificity of 100%. No significant correlation was observed between anti-MCV and disease activity score using 28 joint counts, radiographic RA stage, number of erosions on ultrasonography of joints, and quality-of-life scores at disease onset. The Spearman correlation was significant in early RA patients with positive results of anti-MCV between the titers of this marker and arthritis duration, level of erythrocyte sedimentation rate, and IgM-RF. The best diagnostic strategy in early RA may be to assay both anti-MCV and IgM-RF. Thus, a question arises regarding the possible inclusion of anti-MCV in future revisions of the classification criteria of RA.
    MeSH term(s) Antibodies/blood ; Antibodies/immunology ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/immunology ; Autoantibodies/blood ; Autoantibodies/immunology ; Female ; Humans ; Male ; Middle Aged ; Rheumatoid Factor/blood ; Sensitivity and Specificity ; Vimentin/chemistry ; Vimentin/immunology
    Chemical Substances Antibodies ; Autoantibodies ; Vimentin ; Rheumatoid Factor (9009-79-4)
    Language English
    Publishing date 2012-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 801524-7
    ISSN 1879-1166 ; 0198-8859
    ISSN (online) 1879-1166
    ISSN 0198-8859
    DOI 10.1016/j.humimm.2012.01.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Treatment of early arthritis using arthrofoon (ultra-low doses of antibodies to tumor necrosis factor-α).

    Sizova, Lyudmila V

    Indian journal of pharmacology

    2011  Volume 43, Issue 6, Page(s) 724–725

    Abstract: The main aim of treatment of early rheumatoid arthritis (RA) should be to achieve clinical remission to prevent structural damage and physical disability. Arthrofoon modifies production/activity of endogenous inhibitors of tumor necrosis factor-α (TNF-α). ...

    Abstract The main aim of treatment of early rheumatoid arthritis (RA) should be to achieve clinical remission to prevent structural damage and physical disability. Arthrofoon modifies production/activity of endogenous inhibitors of tumor necrosis factor-α (TNF-α). The sublingual rout is the most acceptable to ambulatory treatment because it does not produce the adverse reactions associated with intravenous therapy. The treatment with arthrofoon in outpatient with early RA is analyzed here. This report is devoted to the 28-year-old Russian woman who received arthrofoon due to suspicion of early RA. The strategy of early prescription of ultra-low doses of TNF-α antibody within two years was confirmed by the clinical improvement and delay of radiological disease progression in patient with undifferentiated arthritis or probable RA initially.
    Language English
    Publishing date 2011-12-05
    Publishing country India
    Document type Journal Article
    ZDB-ID 605829-2
    ISSN 1998-3751 ; 0253-7613
    ISSN (online) 1998-3751
    ISSN 0253-7613
    DOI 10.4103/0253-7613.89836
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.

    Sizova, Lyudmila

    British journal of clinical pharmacology

    2008  Volume 66, Issue 2, Page(s) 173–178

    Abstract: This paper reviews recent approaches to treatment of early rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs (DMARDs). The literature on treatment the early RA published between 1995 and 2007 was accessed through the PubMed database ... ...

    Abstract This paper reviews recent approaches to treatment of early rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs (DMARDs). The literature on treatment the early RA published between 1995 and 2007 was accessed through the PubMed database from the National Library of Medicine. Keywords were 'early rheumatoid arthritis', 'disease-modifying antirheumatic drugs', 'biologic agents' and 'combination therapy'. Only results of trials on human subjects that directly measured the effects of DMARDs or biological agents on clinical, laboratory parameters and radiological progression of early RA were selected. Combination therapy suppresses RA activity and radiological progression more effectively than monotherapy. If better control of RA is evident after 3-6 months of treatment with the combination of DMARDs, one must still decide whether to stop the first DMARD, stop the second, or continue with the combination. Combination therapy biological agents (infliximab, adalimumab) with methotrexate and etanercept therapy alone may induce remission in many patients with early RA. It is a method of choice in patients with an adverse prognosis. The main indications for combination therapy 'standard' DMARDs or combination 1 DMARDs with a biological agent are such variables as detection of a shared epitope, increase of concentration of anticyclic citrullinated peptide antibodies, rheumatoid factor, C-reactive protein, 28-joint disease activity score, Sharp score and presence of erosion in joints. The majority of rheumatologists believe that patients with RA should be treated with DMARDs earlier rather than later in the disease process. Further trials should establish the optimal approaches to early RA therapy.
    MeSH term(s) Antibodies, Monoclonal/therapeutic use ; Antirheumatic Agents/administration & dosage ; Arthritis, Rheumatoid/drug therapy ; Arthritis, Rheumatoid/psychology ; Clinical Trials as Topic ; Disease Progression ; Drug Therapy, Combination ; Humans ; Infliximab ; Isoxazoles/therapeutic use ; Leflunomide ; Methotrexate/therapeutic use ; Quality of Life/psychology ; Severity of Illness Index ; Sulfasalazine/therapeutic use ; Time Factors ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
    Chemical Substances Antibodies, Monoclonal ; Antirheumatic Agents ; Isoxazoles ; Tumor Necrosis Factor-alpha ; Sulfasalazine (3XC8GUZ6CB) ; Infliximab (B72HH48FLU) ; Leflunomide (G162GK9U4W) ; Methotrexate (YL5FZ2Y5U1)
    Language English
    Publishing date 2008-05-15
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 188974-6
    ISSN 1365-2125 ; 0306-5251 ; 0264-3774
    ISSN (online) 1365-2125
    ISSN 0306-5251 ; 0264-3774
    DOI 10.1111/j.1365-2125.2008.03222.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Treatment of early arthritis using arthrofoon (ultra-low doses of antibodies to tumor necrosis factor-α)

    Lyudmila V Sizova

    Indian Journal of Pharmacology, Vol 43, Iss 6, Pp 724-

    2011  Volume 725

    Abstract: The main aim of treatment of early rheumatoid arthritis (RA) should be to achieve clinical remission to prevent structural damage and physical disability. Arthrofoon modifies production/activity of endogenous inhibitors of tumor necrosis factor-α (TNF-α). ...

    Abstract The main aim of treatment of early rheumatoid arthritis (RA) should be to achieve clinical remission to prevent structural damage and physical disability. Arthrofoon modifies production/activity of endogenous inhibitors of tumor necrosis factor-α (TNF-α). The sublingual rout is the most acceptable to ambulatory treatment because it does not produce the adverse reactions associated with intravenous therapy. The treatment with arthrofoon in outpatient with early RA is analyzed here. This report is devoted to the 28-year-old Russian woman who received arthrofoon due to suspicion of early RA. The strategy of early prescription of ultra-low doses of TNF-α antibody within two years was confirmed by the clinical improvement and delay of radiological disease progression in patient with undifferentiated arthritis or probable RA initially.
    Keywords Arthrofoon ; early arthritis ; undifferentiated arthritis ; Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R
    Language English
    Publishing date 2011-01-01T00:00:00Z
    Publisher Medknow Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Assessment of the toxicity of silicon nanooxide in relation to various components of the agroecosystem under the conditions of the model experiment.

    Lebedev, Svyatoslav Valeryevich / Gavrish, Irina Aleksandrovna / Galaktionova, Lyudmila Vyacheslavovna / Korotkova, Anastasia Mickhailovna / Sizova, Elena Anatolyevna

    Environmental geochemistry and health

    2018  Volume 41, Issue 2, Page(s) 769–782

    Abstract: Investigation of ... ...

    Abstract Investigation of SiO
    MeSH term(s) Animals ; Biomass ; Catalase/metabolism ; Nanoparticles ; Oligochaeta/drug effects ; Silicon Dioxide/toxicity ; Soil/chemistry ; Soil Pollutants/analysis ; Superoxide Dismutase/metabolism ; Triticum/metabolism
    Chemical Substances Soil ; Soil Pollutants ; Silicon Dioxide (7631-86-9) ; Catalase (EC 1.11.1.6) ; Superoxide Dismutase (EC 1.15.1.1)
    Language English
    Publishing date 2018-08-18
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 52039-1
    ISSN 1573-2983 ; 0142-7245 ; 0269-4042
    ISSN (online) 1573-2983
    ISSN 0142-7245 ; 0269-4042
    DOI 10.1007/s10653-018-0171-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Impact of molybdenum nanoparticles on survival, activity of enzymes, and chemical elements in Eisenia fetida using test on artificial substrata.

    Lebedev, Sviatoslav / Yausheva, Elena / Galaktionova, Lyudmila / Sizova, Elena

    Environmental science and pollution research international

    2016  Volume 23, Issue 18, Page(s) 18099–18110

    Abstract: The influence of molybdenum oxide nanoparticles (MoO3) on the growth and survival of Eisenia fetida was established. The activity of antioxidant enzymes and changes in concentration of molybdenum in the body of E. fetida were determined. The degree of ... ...

    Abstract The influence of molybdenum oxide nanoparticles (MoO3) on the growth and survival of Eisenia fetida was established. The activity of antioxidant enzymes and changes in concentration of molybdenum in the body of E. fetida were determined. The degree of bacterial bioluminescence inhibition in extracts of substrates and worm was studied using luminescent strain Escherichia coli K12 TG1. The enzymatic activity of substrates before and after exposure with nanoparticles and worms was assessed. Nanoparticles have concentrations of 10, 40, and 500 mg/kg of dry matter, and substrata are made of artificial soil (substrate A) and microcrystalline cellulose (substrate B). Spherical nanoparticles MoO3, yellow in color, with size 92 ± 0.3 nm, Z-potential 42 ± 0.52 mV, molybdenum content 99.8 mass/%, and specific area 12 m(2)/g were used in the study. A significant decrease by 23.3 % in weight was registered (for MoO3 NPs at 500 mg/kg) on substrate A (p ≤ 0.05). On substrate B, the maximum decrease in weight by 20.5, 33.3, and 16.9 % (p ≤ 0.05) was registered at a dose of 10, 40, and 500 mg/kg, respectively; mortality was from 6.6 to 73 %. After the assessment of bacterial bioluminescence inhibition in substrates A and B (extracts) and before worms were put, the toxicity of substrates was established at doses of 40 and 500 mg/kg, expressed in inhibitory concentration (IC) 30 and IC 50 values. Comparatively, on days 7 and 14, after exposure in the presence of E. fetida, no inhibition of bioluminescence was registered in extracts of substrates A and B, indicating the reduction in toxicity of substrates. The initial content of molybdenum in E. fetida was 0.9 ± 0.018 mg/kg of dry matter. The degree of molybdenum accumulation in worm tissue was dependent on the dose and substrate quality. In particular, 2-7 mg/kg of molybdenum accumulated from substrate A, while up to 15 kg/kg of molybdenum accumulated from substrate B (day 7). Molybdenum concentration decreased by 64.8 and 57.4 % at doses 40 and 500 mg/kg, respectively, on day 14. The reaction of antioxidant enzymes was shown in an insignificant increase of glutathione reductase (GSR) and catalase (CAT) at concentrations of 10 and 40 mg/kg in substrate A, followed by the subsequent reduction of their activity at the dose of 500 mg/kg MoO3. The activity of GSR in substrate B against the presence of MoO3 nanoparticles decreased, with significant difference of 33.5 % (p ≤ 0.05) at the dose of 500 mg/kg compared with untreated soil. In experiments with substrate A, an increase of catalase activity was registered for the control sample. The presence of MoO3 nanoparticles at the concentration of 10 mg/kg in the environment promoted enzymatic activity on days 7 and 14, respectively. A further increase of nanoparticle concentration resulted in the decrease of catalase activity with a minimum value at the concentration of MoO3 of 500 mg/kg. In the experiment with substrate B at the concentration of MoO3 nanoparticles of 40 mg/kg, enzymatic activity increases on day 7 of exposure. However, the stimulating effect of nanoparticles stops by day 14 of the experiment and further catalase activity is dose dependent with the smallest value in the experiment with MoO3 having the concentration of 500 mg/kg.
    MeSH term(s) Animals ; Antioxidants/metabolism ; Catalase/metabolism ; Escherichia coli K12 ; Molybdenum/toxicity ; Nanoparticles/toxicity ; Oligochaeta/drug effects ; Oligochaeta/enzymology ; Oligochaeta/growth & development ; Oxidation-Reduction ; Oxides/toxicity ; Soil ; Soil Pollutants/toxicity ; Superoxide Dismutase/metabolism ; Toxicity Tests
    Chemical Substances Antioxidants ; Oxides ; Soil ; Soil Pollutants ; molybdenum trioxide (22FQ3F03YS) ; Molybdenum (81AH48963U) ; Catalase (EC 1.11.1.6) ; Superoxide Dismutase (EC 1.15.1.1)
    Language English
    Publishing date 2016-09
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1178791-0
    ISSN 1614-7499 ; 0944-1344
    ISSN (online) 1614-7499
    ISSN 0944-1344
    DOI 10.1007/s11356-016-6916-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A fluorescent microspheres-based microfluidic test system for the detection of immunoglobulin G to SARS-CoV-2

    Ruslan I. Shakurov / Yaroslav D. Shansky / Kirill A. Prusakov / Svetlana V. Sizova / Stepan P. Dudik / Lyudmila V. Plotnikova / Valentin A. Manuvera / Dmitry V. Klinov / Vassili N. Lazarev / Julia A. Bespyatykh / Dmitriy V. Basmanov

    Клиническая практика, Vol 14, Iss 1, Pp 44-

    2023  Volume 53

    Abstract: Background: The pandemic of the new coronavirus infection, COVID-19, is currently ongoing in the world. Over the years, the pathogen, SARS-CoV-2, has undergone a series of mutational genome changes, which has led to the spread of various genetic variants ...

    Abstract Background: The pandemic of the new coronavirus infection, COVID-19, is currently ongoing in the world. Over the years, the pathogen, SARS-CoV-2, has undergone a series of mutational genome changes, which has led to the spread of various genetic variants of the virus. Meanwhile, the methods used to diagnose SARS-CoV-2, to establish the disease stage and to assess the immunity, are nonspecific to SARS-CoV-2 variants and time-consumable. Thus, the development of new methods for diagnosing COVID-19, as well as their implementation in practice, is currently an important direction. In particular, application of systems based on chemically modified fluorescent microspheres (with a multiplex assay for target protein molecules) opens great opportunities. Aim: development of a microfluidic diagnostic test system based on fluorescent microspheres for the specific detection of immunoglobulins G (IgG) to SARS-CoV-2. Methods: A collection of human serum samples was characterized using enzyme-linked immunosorbent assay (ELISA) and commercially available reagent kits. IgG to SARS-CoV-2 in the human serum were detected by the developed immunofluorescent method using microspheres containing the chemically immobilized RBD fragment of the SARS-CoV-2 (Kappa variant) viral S-protein. Results: The level of IgG in the blood serum of recovered volunteers was 9-300 times higher than that in apparently healthy volunteers, according to ELISA (p0.001). Conjugates of fluorescent microspheres with the RBD-fragment of the S-protein, capable of specifically binding IgG from the blood serum, have been obtained. The immune complexes formation was confirmed by the fluorescence microscopy data; the fluorescence intensity of secondary antibodies in the immune complexes formed on the surface of microspheres was proportional to the content of IgG (r 0.963). The test system had a good predictive value (AUC 70.3%). Conclusion: A test system has been developed, based on fluorescent microspheres containing the immobilized RBD fragment of the SARS-CoV-2 ...
    Keywords enzyme-linked immunosorbent assay ; elisa ; covid-19 testing ; personalized medicine ; Medicine ; R
    Subject code 600
    Language English
    Publishing date 2023-04-01T00:00:00Z
    Publisher Eco-vector
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Impact of molybdenum nanoparticles on survival, activity of enzymes, and chemical elements in Eisenia fetida using test on artificial substrata

    Lebedev, Sviatoslav / Elena Sizova / Elena Yausheva / Lyudmila Galaktionova

    Environmental science and pollution research international. 2016 Sept., v. 23, no. 18

    2016  

    Abstract: The influence of molybdenum oxide nanoparticles (MoO₃) on the growth and survival of Eisenia fetida was established. The activity of antioxidant enzymes and changes in concentration of molybdenum in the body of E. fetida were determined. The degree of ... ...

    Abstract The influence of molybdenum oxide nanoparticles (MoO₃) on the growth and survival of Eisenia fetida was established. The activity of antioxidant enzymes and changes in concentration of molybdenum in the body of E. fetida were determined. The degree of bacterial bioluminescence inhibition in extracts of substrates and worm was studied using luminescent strain Escherichia coli K12 TG1. The enzymatic activity of substrates before and after exposure with nanoparticles and worms was assessed. Nanoparticles have concentrations of 10, 40, and 500 mg/kg of dry matter, and substrata are made of artificial soil (substrate A) and microcrystalline cellulose (substrate B). Spherical nanoparticles MoO₃, yellow in color, with size 92 ± 0.3 nm, Z-potential 42 ± 0.52 mV, molybdenum content 99.8 mass/%, and specific area 12 m²/g were used in the study. A significant decrease by 23.3 % in weight was registered (for MoO₃ NPs at 500 mg/kg) on substrate A (p ≤ 0.05). On substrate B, the maximum decrease in weight by 20.5, 33.3, and 16.9 % (p ≤ 0.05) was registered at a dose of 10, 40, and 500 mg/kg, respectively; mortality was from 6.6 to 73 %. After the assessment of bacterial bioluminescence inhibition in substrates A and B (extracts) and before worms were put, the toxicity of substrates was established at doses of 40 and 500 mg/kg, expressed in inhibitory concentration (IC) 30 and IC 50 values. Comparatively, on days 7 and 14, after exposure in the presence of E. fetida, no inhibition of bioluminescence was registered in extracts of substrates A and B, indicating the reduction in toxicity of substrates. The initial content of molybdenum in E. fetida was 0.9 ± 0.018 mg/kg of dry matter. The degree of molybdenum accumulation in worm tissue was dependent on the dose and substrate quality. In particular, 2–7 mg/kg of molybdenum accumulated from substrate A, while up to 15 kg/kg of molybdenum accumulated from substrate B (day 7). Molybdenum concentration decreased by 64.8 and 57.4 % at doses 40 and 500 mg/kg, respectively, on day 14. The reaction of antioxidant enzymes was shown in an insignificant increase of glutathione reductase (GSR) and catalase (CAT) at concentrations of 10 and 40 mg/kg in substrate A, followed by the subsequent reduction of their activity at the dose of 500 mg/kg MoO₃. The activity of GSR in substrate B against the presence of MoO₃ nanoparticles decreased, with significant difference of 33.5 % (p ≤ 0.05) at the dose of 500 mg/kg compared with untreated soil. In experiments with substrate A, an increase of catalase activity was registered for the control sample. The presence of MoO₃ nanoparticles at the concentration of 10 mg/kg in the environment promoted enzymatic activity on days 7 and 14, respectively. A further increase of nanoparticle concentration resulted in the decrease of catalase activity with a minimum value at the concentration of MoO₃ of 500 mg/kg. In the experiment with substrate B at the concentration of MoO₃ nanoparticles of 40 mg/kg, enzymatic activity increases on day 7 of exposure. However, the stimulating effect of nanoparticles stops by day 14 of the experiment and further catalase activity is dose dependent with the smallest value in the experiment with MoO₃ having the concentration of 500 mg/kg.
    Keywords antioxidants ; bioluminescence ; catalase ; cellulose ; color ; dose response ; Eisenia fetida ; enzyme activity ; Escherichia coli K12 ; glutathione-disulfide reductase ; inhibitory concentration 50 ; molybdenum ; mortality ; nanoparticles ; soil ; toxicity
    Language English
    Dates of publication 2016-09
    Size p. 18099-18110.
    Publishing place Springer Berlin Heidelberg
    Document type Article
    ZDB-ID 1178791-0
    ISSN 1614-7499 ; 0944-1344
    ISSN (online) 1614-7499
    ISSN 0944-1344
    DOI 10.1007/s11356-016-6916-6
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article: Assessment of the toxicity of silicon nanooxide in relation to various components of the agroecosystem under the conditions of the model experiment

    Lebedev, Svyatoslav Valeryevich / Galaktionova, Lyudmila Vyacheslavovna / Gavrish, Irina Aleksandrovna / Korotkova, Anastasia Mickhailovna / Sizova, Elena Anatolyevna

    Environmental geochemistry and health. 2019 Apr., v. 41, no. 2

    2019  

    Abstract: Investigation of SiO2 nanoparticles (NPs) effect on Eisenia fetida showed no toxic effect of the metal at a concentration of 250, 500 and 1000 mg per kg of soil, but conversely, a biomass increase from 23.5 to 29.5% (at the protein level decrease from 60 ...

    Abstract Investigation of SiO2 nanoparticles (NPs) effect on Eisenia fetida showed no toxic effect of the metal at a concentration of 250, 500 and 1000 mg per kg of soil, but conversely, a biomass increase from 23.5 to 29.5% (at the protein level decrease from 60 to 80%). The reaction of the earthworm organism fermentative system was expressed in the decrease in the level of superoxide dismutase (SOD) on the 14th day and in the increase in its activity to 27% on the 28th day. The catalase level (CAT) showed low activity at average element concentrations and increase by 39.4% at a dose of 1000 mg/kg. Depression of malonic dialdehyde (MDA) was established at average concentrations of 11.2% and level increase up to 9.1% at a dose of 1000 mg/kg with the prolongation of the effect up to 87.5% after 28-day exposure. The change in the microbiocenosis of the earthworm intestine was manifested by a decrease in the number of ammonifiers (by 42.01–78.9%), as well as in the number of amylolytic microorganisms (by 31.7–65.8%). When the dose of SiO2 NPs increased from 100 to 1000 mg/kg, the number of Azotobacter increased (by 8.2–22.2%), while the number of cellulose-destroying microorganisms decreased to 71.4% at a maximum dose of 1000 mg/kg. The effect of SiO2 NPs on Triticum aestivum L. was noted in the form of a slight suppression of seed germination (no more than 25%), an increase in the length of roots and aerial organs which generally resulted in an increase in plant biomass. Assessing the soil microorganisms’ complex during introduction of metal into the germination medium of Triticum aestivum L., there was noted a decrease in the ammonifiers number (by 4.7–67.6%) with a maximum value at a dose of 1000 mg/kg. The number of microorganisms using mineral nitrogen decreased by 29.5–69.5% with a simultaneous increase in the number at a dose of 50 mg/kg (+ 20%). Depending on NP dose, there was an inhibition of the microscopic fungi development by 18.1–72.7% and an increase in the number of cellulose-destroying microorganisms. For all variants of the experiment, the activity of soil enzymes of the hydrolase and oxidoreductase classes was decreased.
    Keywords agroecosystems ; Azotobacter ; catalase ; earthworms ; Eisenia fetida ; fungi ; germination ; hydrolases ; intestines ; models ; nanoparticles ; nitrogen ; phytomass ; protein content ; roots ; silica ; silicon ; soil ; soil enzymes ; soil microorganisms ; superoxide dismutase ; toxicity ; Triticum aestivum
    Language English
    Dates of publication 2019-04
    Size p. 769-782.
    Publishing place Springer Netherlands
    Document type Article
    ZDB-ID 52039-1
    ISSN 1573-2983 ; 0142-7245 ; 0269-4042
    ISSN (online) 1573-2983
    ISSN 0142-7245 ; 0269-4042
    DOI 10.1007/s10653-018-0171-3
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top